PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PIK3CA mutations are common in ...... ot a biomarker of progression.
@en
PIK3CA mutations are common in ...... ot a biomarker of progression.
@nl
type
label
PIK3CA mutations are common in ...... ot a biomarker of progression.
@en
PIK3CA mutations are common in ...... ot a biomarker of progression.
@nl
prefLabel
PIK3CA mutations are common in ...... ot a biomarker of progression.
@en
PIK3CA mutations are common in ...... ot a biomarker of progression.
@nl
P2093
P2860
P50
P1476
PIK3CA mutations are common in ...... not a biomarker of progression
@en
P2093
Cheryl Gillett
Irek Shinomiya
Narda Kebaier Ep Chaabouni
Rebecca Roylance
Salpie Nowinski
Trevor A Graham
Vandna Shah
P2860
P2888
P356
10.1186/S13058-016-0789-Y
P577
2017-01-17T00:00:00Z
P6179
1027189133